Company Filing History:
1 out of 15 
1 out of 5,076 
1 out of 6 Years Active: 2006-2018
Title: Alain Friboulet: Innovator in Cancer Treatment and Antibody Modulation
Introduction
Alain Friboulet is a notable inventor based in Jonquieres, France. He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for cancer and the modulation of antibody activity. With a total of 2 patents, Friboulet's work has the potential to impact therapeutic approaches in oncology and enzymatic deficiencies.
Latest Patents
Friboulet's latest patents include groundbreaking inventions such as STAT5 inhibitors and their use in cancer treatment. This invention provides a composition of matter that binds specifically to STAT5, particularly STAT5B, and includes a nucleic acid aptamer. The methods outlined in this patent focus on treating cancer, especially leukemia, through the inhibition of the STAT5 protein. Additionally, he has developed a method for detecting STAT5 in biological samples, which involves using a nucleic acid aptamer that binds specifically to STAT5.
Another significant patent involves compounds capable of modulating the activity and stimulating the production of catalytic antibodies. This invention describes novel compounds that can enhance the activity of antibodies with specific affinity for their catalytic sites. These compounds are non-immunogenic and are particularly useful for therapeutic treatments related to enzymatic deficiencies, as well as for preventing or inhibiting allergic reactions.
Career Highlights
Throughout his career, Alain Friboulet has worked with esteemed institutions such as the Université de Technologie de Compiègne and the Centre National de la Recherche Scientifique. His research has focused on innovative solutions to complex medical challenges, showcasing his dedication to advancing healthcare through scientific discovery.
Collaborations
Friboulet has collaborated with notable colleagues, including Berangere Avalle-Bihan and Claire Loussouarn. These partnerships have contributed to the development of his patents and the advancement of research in his field.
Conclusion
Alain Friboulet stands out as an influential inventor whose work in cancer treatment and antibody modulation holds promise for future medical advancements. His contributions reflect a commitment to innovation and the pursuit of effective therapeutic solutions.